We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KEN:NYSEKenon Holdings Ltd. Analysis

Data as of 2026-05-19 - not real-time

$84.57

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Kenon Holdings is trading below its 20‑day (≈$88) and 50‑day (≈$85) simple moving averages, yet remains comfortably above its 200‑day average (≈$65), signaling a long‑term bullish backdrop despite short‑term weakness. The RSI sits near the mid‑range at about 45, indicating neutral momentum, while the MACD histogram is negative, reinforcing a bearish tilt in the near term. Volatility is elevated (over 50% 30‑day) and beta is close to 1, suggesting the stock moves in line with the market but with amplified swings. Fundamentally, revenue surged 43% year‑over‑year, but margins are thin and the price‑to‑earnings ratio (≈66) vastly exceeds the industry average (≈21), while a discounted cash‑flow model values the company near $18 – a stark contrast to the current price of $84. A dividend yield of 4.55% looks attractive, yet the payout ratio exceeds 300%, making the dividend financially unsustainable. Recent headlines note an all‑time high of $91.41, highlighting recent enthusiasm, but the price has retreated, aligning with the technical signals of short‑term pressure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below short‑term SMAs indicating near‑term weakness
  • Bearish MACD histogram and neutral RSI
  • Increasing volume but high short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Long‑term price above 200‑day SMA supporting bullish bias
  • Robust 43% revenue growth and expanding cash position
  • Persistent overvaluation relative to peers and DCF

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Extreme price vs. DCF fair value indicating likely correction
  • Unsustainable dividend payout ratio
  • High valuation multiples and elevated volatility

Key Metrics & Analysis

Financial Health

Revenue Growth43.10%
Profit Margin7.60%
P/E Ratio66.6
ROE5.07%
ROA0.81%
Debt/Equity55.87
P/B Ratio2.8
Op. Cash Flow$283.8M
Free Cash Flow$32.0M
Industry P/E21.3

Technical Analysis

TrendBullish
RSI45.4
Support$78.42
Resistance$95.93
MA 20$87.99
MA 50$84.85
MA 200$64.91
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair Value$18.09
GradeOvervalued
TypeGrowth
Dividend Yield4.55%

Risk Assessment

Beta0.95
Volatility52.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.